Emergence of carbapenemases in Pseudomonas aeruginosa: a worldwide problem

  title={Emergence of carbapenemases in Pseudomonas aeruginosa: a worldwide problem},
  author={M. Gomila},
  journal={Expert Review of Anti-infective Therapy},
  pages={11 - 9}
  • M. Gomila
  • Published 2014
  • Biology, Medicine
  • Expert Review of Anti-infective Therapy
  • Evaluation of: Edelstein MV, Skleenova EN, Shevchenko OV et al. Spread of extensively resistant VIM-2-positive ST235 Pseudomonas aeruginosa in Belarus, Kazakhstan, and Russia: a longitudinal epidemiological and clinical study. Lancet Infect. Dis. 13(10), 867–876 (2013). The emergence of carbapenemases-producing Pseudomonas aeruginosa isolates, resistant to all antibiotics except colistin, is an important health problem due to the lack of effective antibiotic treatments. This article assesses… CONTINUE READING
    4 Citations

    Topics from this paper.


    Complexity of resistance mechanisms to imipenem in intensive care unit strains of Pseudomonas aeruginosa.
    • 64
    • PDF
    Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem.
    • 122
    • PDF
    Emerging carbapenemases: a global perspective.
    • T. Walsh
    • Biology, Medicine
    • International journal of antimicrobial agents
    • 2010
    • 431
    • PDF
    Outbreaks of Multidrug-Resistant Pseudomonas aeruginosa in Community Hospitals in Japan
    • 99
    • PDF